Novo Nordisk stock slips 0.49% to EUR 36.63 before Xetra
Published on 11/18/2026 at 07:53 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey points for investors
- Novo Nordisk is a Danish pharmaceutical company focused on prescription medicines.
- The company develops treatments for approved indications across multiple disease areas.
Novo Nordisk stock traded at EUR 36.63 on Lang & Schwarz at 07:51 CET on Wednesday, November 18, 2026, 0.49 percent below the Xetra close of Tuesday, November 17, at EUR 36.81.
The Danish pharmaceutical company develops and sells prescription medicines for approved indications across multiple disease areas.
European equities trade in the broader Euro Stoxx 50 market context.
Disclaimer...
en | DK0062498333 | NOVO-NORDISK | boerse | 70529803 | bgmi
